<!doctype html>
<html lang="en">
  <head>
    <meta charset="utf-8">
    <meta name="viewport" content="width=device-width, initial-scale=1">
  </head>
  <body>
    <h2>liu-2019/PC</h2>
    <p><a href="https://www.cycif.org/data/liu-2019/PC">https://www.cycif.org/data/liu-2019/PC</a></p>
    <ul>
      <li>aSMA in groups: Architecure, Differentiation State</li>
    </ul>
    <h2>liu-2019/PM</h2>
    <p><a href="https://www.cycif.org/data/liu-2019/PM">https://www.cycif.org/data/liu-2019/PM</a></p>
    <ul>
      <li>aSMA in groups: Architecure, Differentiation State</li>
    </ul>
    <h2>liu-2019/D1307880A2</h2>
    <p><a href="https://www.cycif.org/data/liu-2019/D1307880A2">https://www.cycif.org/data/liu-2019/D1307880A2</a></p>
    <ul>
      <li>CD45 in groups: Architecure, Differentiation State</li>
      <li>aSMA in groups: Architecure, Differentiation State</li>
    </ul>
    <h2>liu-2019/PJ</h2>
    <p><a href="https://www.cycif.org/data/liu-2019/PJ">https://www.cycif.org/data/liu-2019/PJ</a></p>
    <ul>
      <li>aSMA in groups: Architecure, Differentiation State</li>
    </ul>
    <h2>liu-2019/P4</h2>
    <p><a href="https://www.cycif.org/data/liu-2019/P4">https://www.cycif.org/data/liu-2019/P4</a></p>
    <ul>
      <li>aSMA in groups: Architecure, Differentiation State</li>
    </ul>
    <h2>liu-2019/PK</h2>
    <p><a href="https://www.cycif.org/data/liu-2019/PK">https://www.cycif.org/data/liu-2019/PK</a></p>
    <ul>
      <li>aSMA in groups: Architecure, Differentiation State</li>
    </ul>
    <h2>liu-2019/PL</h2>
    <p><a href="https://www.cycif.org/data/liu-2019/PL">https://www.cycif.org/data/liu-2019/PL</a></p>
    <ul>
      <li>aSMA in groups: Architecure, Differentiation State</li>
    </ul>
    <h2>liu-2019/D1307880B2</h2>
    <p><a href="https://www.cycif.org/data/liu-2019/D1307880B2">https://www.cycif.org/data/liu-2019/D1307880B2</a></p>
    <ul>
      <li>CD45 in groups: Architecure, Differentiation State</li>
      <li>aSMA in groups: Architecure, Differentiation State</li>
    </ul>
    <h2>liu-2019/PE</h2>
    <p><a href="https://www.cycif.org/data/liu-2019/PE">https://www.cycif.org/data/liu-2019/PE</a></p>
    <ul>
      <li>aSMA in groups: Architecure, Differentiation State</li>
    </ul>
    <h2>liu-2019/PB</h2>
    <p><a href="https://www.cycif.org/data/liu-2019/PB">https://www.cycif.org/data/liu-2019/PB</a></p>
    <ul>
      <li>aSMA in groups: Architecure, Differentiation State</li>
    </ul>
    <h2>liu-2019/D1400257B7</h2>
    <p><a href="https://www.cycif.org/data/liu-2019/D1400257B7">https://www.cycif.org/data/liu-2019/D1400257B7</a></p>
    <ul>
      <li>CD45 in groups: Architecure, Differentiation State</li>
      <li>aSMA in groups: Architecure, Differentiation State</li>
    </ul>
    <h2>liu-2019/PP</h2>
    <p><a href="https://www.cycif.org/data/liu-2019/PP">https://www.cycif.org/data/liu-2019/PP</a></p>
    <ul>
      <li>aSMA in groups: Architecure, Differentiation State</li>
    </ul>
    <h2>liu-2019/P2</h2>
    <p><a href="https://www.cycif.org/data/liu-2019/P2">https://www.cycif.org/data/liu-2019/P2</a></p>
    <ul>
      <li>aSMA in groups: Architecure, Differentiation State</li>
    </ul>
    <h2>liu-2019/P5</h2>
    <p><a href="https://www.cycif.org/data/liu-2019/P5">https://www.cycif.org/data/liu-2019/P5</a></p>
    <ul>
      <li>aSMA in groups: Architecure, Differentiation State</li>
    </ul>
    <h2>liu-2019/D1308200D5</h2>
    <p><a href="https://www.cycif.org/data/liu-2019/D1308200D5">https://www.cycif.org/data/liu-2019/D1308200D5</a></p>
    <ul>
      <li>CD45 in groups: Architecure, Differentiation State</li>
      <li>aSMA in groups: Architecure, Differentiation State</li>
    </ul>
    <h2>liu-2019/N1</h2>
    <p><a href="https://www.cycif.org/data/liu-2019/N1">https://www.cycif.org/data/liu-2019/N1</a></p>
    <ul>
      <li>aSMA in groups: Architecure, Differentiation State</li>
    </ul>
    <h2>liu-2019/D1401032A7</h2>
    <p><a href="https://www.cycif.org/data/liu-2019/D1401032A7">https://www.cycif.org/data/liu-2019/D1401032A7</a></p>
    <ul>
      <li>CD45 in groups: Architecure, Differentiation State</li>
      <li>aSMA in groups: Architecure, Differentiation State</li>
    </ul>
    <h2>liu-2019/D1308200C2</h2>
    <p><a href="https://www.cycif.org/data/liu-2019/D1308200C2">https://www.cycif.org/data/liu-2019/D1308200C2</a></p>
    <ul>
      <li>CD45 in groups: Architecure, Differentiation State</li>
      <li>aSMA in groups: Architecure, Differentiation State</li>
    </ul>
    <h2>liu-2019/D1400617C4</h2>
    <p><a href="https://www.cycif.org/data/liu-2019/D1400617C4">https://www.cycif.org/data/liu-2019/D1400617C4</a></p>
    <ul>
      <li>CD45 in groups: Architecure, Differentiation State</li>
      <li>aSMA in groups: Architecure, Differentiation State</li>
    </ul>
    <h2>liu-2019/98DTF1697</h2>
    <p><a href="https://www.cycif.org/data/liu-2019/98DTF1697">https://www.cycif.org/data/liu-2019/98DTF1697</a></p>
    <ul>
      <li>CD45 in groups: Architecure, Differentiation State</li>
      <li>aSMA in groups: Architecure, Differentiation State</li>
    </ul>
    <h2>liu-2019/98DTF1433</h2>
    <p><a href="https://www.cycif.org/data/liu-2019/98DTF1433">https://www.cycif.org/data/liu-2019/98DTF1433</a></p>
    <ul>
      <li>CD45 in groups: Architecure, Differentiation State</li>
      <li>aSMA in groups: Architecure, Differentiation State</li>
    </ul>
    <h2>liu-2019/98DTF14515</h2>
    <p><a href="https://www.cycif.org/data/liu-2019/98DTF14515">https://www.cycif.org/data/liu-2019/98DTF14515</a></p>
    <ul>
      <li>CD45 in groups: Architecure, Differentiation State</li>
      <li>aSMA in groups: Architecure, Differentiation State</li>
    </ul>
    <h2>liu-2019/D1307880D2</h2>
    <p><a href="https://www.cycif.org/data/liu-2019/D1307880D2">https://www.cycif.org/data/liu-2019/D1307880D2</a></p>
    <ul>
      <li>CD45 in groups: Architecure, Differentiation State</li>
      <li>aSMA in groups: Architecure, Differentiation State</li>
    </ul>
    <h2>liu-2019/P7</h2>
    <p><a href="https://www.cycif.org/data/liu-2019/P7">https://www.cycif.org/data/liu-2019/P7</a></p>
    <ul>
      <li>aSMA in groups: Architecure, Differentiation State</li>
    </ul>
    <h2>liu-2019/P9</h2>
    <p><a href="https://www.cycif.org/data/liu-2019/P9">https://www.cycif.org/data/liu-2019/P9</a></p>
    <ul>
      <li>aSMA in groups: Architecure, Differentiation State</li>
    </ul>
    <h2>liu-2019/PG</h2>
    <p><a href="https://www.cycif.org/data/liu-2019/PG">https://www.cycif.org/data/liu-2019/PG</a></p>
    <ul>
      <li>aSMA in groups: Architecure, Differentiation State</li>
    </ul>
    <h2>liu-2019/D1306783A2</h2>
    <p><a href="https://www.cycif.org/data/liu-2019/D1306783A2">https://www.cycif.org/data/liu-2019/D1306783A2</a></p>
    <ul>
      <li>CD45 in groups: Architecure, Differentiation State</li>
      <li>aSMA in groups: Architecure, Differentiation State</li>
    </ul>
    <h2>liu-2019/P8</h2>
    <p><a href="https://www.cycif.org/data/liu-2019/P8">https://www.cycif.org/data/liu-2019/P8</a></p>
    <ul>
      <li>aSMA in groups: Architecure, Differentiation State</li>
    </ul>
    <h2>liu-lin-2019/P6</h2>
    <p><a href="https://www.cycif.org/data/liu-lin-2019/P6">https://www.cycif.org/data/liu-lin-2019/P6</a></p>
    <ul>
      <li>aSMA in groups: Architecure, Differentiation State</li>
    </ul>
    <h2>liu-2019/P1</h2>
    <p><a href="https://www.cycif.org/data/liu-2019/P1">https://www.cycif.org/data/liu-2019/P1</a></p>
    <ul>
      <li>aSMA in groups: Architecure, Differentiation State</li>
    </ul>
    <h2>liu-2019/PO</h2>
    <p><a href="https://www.cycif.org/data/liu-2019/PO">https://www.cycif.org/data/liu-2019/PO</a></p>
    <ul>
      <li>aSMA in groups: Architecure, Differentiation State</li>
    </ul>
    <h2>liu-2019/PH</h2>
    <p><a href="https://www.cycif.org/data/liu-2019/PH">https://www.cycif.org/data/liu-2019/PH</a></p>
    <ul>
      <li>aSMA in groups: Architecure, Differentiation State</li>
    </ul>
    <h2>liu-2019/D1400257A2</h2>
    <p><a href="https://www.cycif.org/data/liu-2019/D1400257A2">https://www.cycif.org/data/liu-2019/D1400257A2</a></p>
    <ul>
      <li>CD45 in groups: Architecure, Differentiation State</li>
      <li>aSMA in groups: Architecure, Differentiation State</li>
    </ul>
    <h2>liu-2019/PA</h2>
    <p><a href="https://www.cycif.org/data/liu-2019/PA">https://www.cycif.org/data/liu-2019/PA</a></p>
    <ul>
      <li>aSMA in groups: Architecure, Differentiation State</li>
    </ul>
    <h2>liu-2019/PF</h2>
    <p><a href="https://www.cycif.org/data/liu-2019/PF">https://www.cycif.org/data/liu-2019/PF</a></p>
    <ul>
      <li>aSMA in groups: Architecure, Differentiation State</li>
    </ul>
    <h2>liu-2019/D1400617A4</h2>
    <p><a href="https://www.cycif.org/data/liu-2019/D1400617A4">https://www.cycif.org/data/liu-2019/D1400617A4</a></p>
    <ul>
      <li>CD45 in groups: Architecure, Differentiation State</li>
      <li>aSMA in groups: Architecure, Differentiation State</li>
    </ul>
    <h2>liu-2019/D1308200A2</h2>
    <p><a href="https://www.cycif.org/data/liu-2019/D1308200A2">https://www.cycif.org/data/liu-2019/D1308200A2</a></p>
    <ul>
      <li>CD45 in groups: Architecure, Differentiation State</li>
      <li>aSMA in groups: Architecure, Differentiation State</li>
    </ul>
    <h2>liu-2019/D1400617B2</h2>
    <p><a href="https://www.cycif.org/data/liu-2019/D1400617B2">https://www.cycif.org/data/liu-2019/D1400617B2</a></p>
    <ul>
      <li>CD45 in groups: Architecure, Differentiation State</li>
      <li>aSMA in groups: Architecure, Differentiation State</li>
    </ul>
    <h2>liu-2019/D1308200B4</h2>
    <p><a href="https://www.cycif.org/data/liu-2019/D1308200B4">https://www.cycif.org/data/liu-2019/D1308200B4</a></p>
    <ul>
      <li>CD45 in groups: Architecure, Differentiation State</li>
      <li>aSMA in groups: Architecure, Differentiation State</li>
    </ul>
    <h2>liu-2019/98DTF1425</h2>
    <p><a href="https://www.cycif.org/data/liu-2019/98DTF1425">https://www.cycif.org/data/liu-2019/98DTF1425</a></p>
    <ul>
      <li>CD45 in groups: Architecure, Differentiation State</li>
      <li>aSMA in groups: Architecure, Differentiation State</li>
    </ul>
    <h2>liu-2019/N3</h2>
    <p><a href="https://www.cycif.org/data/liu-2019/N3">https://www.cycif.org/data/liu-2019/N3</a></p>
    <ul>
      <li>aSMA in groups: Architecure, Differentiation State</li>
    </ul>
    <h2>liu-2019/D1401032B2</h2>
    <p><a href="https://www.cycif.org/data/liu-2019/D1401032B2">https://www.cycif.org/data/liu-2019/D1401032B2</a></p>
    <ul>
      <li>CD45 in groups: Architecure, Differentiation State</li>
      <li>aSMA in groups: Architecure, Differentiation State</li>
    </ul>
    <h2>liu-2019/N2</h2>
    <p><a href="https://www.cycif.org/data/liu-2019/N2">https://www.cycif.org/data/liu-2019/N2</a></p>
    <ul>
      <li>aSMA in groups: Architecure, Differentiation State</li>
    </ul>
    <h2>liu-2019/D1401032C1</h2>
    <p><a href="https://www.cycif.org/data/liu-2019/D1401032C1">https://www.cycif.org/data/liu-2019/D1401032C1</a></p>
    <ul>
      <li>CD45 in groups: Architecure, Differentiation State</li>
      <li>aSMA in groups: Architecure, Differentiation State</li>
    </ul>
    <h2>liu-2019/D1307880C2</h2>
    <p><a href="https://www.cycif.org/data/liu-2019/D1307880C2">https://www.cycif.org/data/liu-2019/D1307880C2</a></p>
    <ul>
      <li>CD45 in groups: Architecure, Differentiation State</li>
      <li>aSMA in groups: Architecure, Differentiation State</li>
    </ul>
    <h2>gaglia-nat-cell-biol-2020/osd-COLON_1</h2>
    <p><a href="https://www.cycif.org/data/gaglia-nat-cell-biol-2020/osd-COLON_1">https://www.cycif.org/data/gaglia-nat-cell-biol-2020/osd-COLON_1</a></p>
    <ul>
      <li>HSF1 in groups: HSF1 Foci, Chaperones</li>
    </ul>
    <h2>osd-3d-1</h2>
    <p><a href="https://www.cycif.org/data/osd-3d-1">https://www.cycif.org/data/osd-3d-1</a></p>
    <ul>
      <li>CD3 in groups: T-Cells, PD-1/PD-L1</li>
    </ul>
    <h2>pca-2019/osd-3_cycif</h2>
    <p><a href="https://www.cycif.org/data/pca-2019/osd-3_cycif">https://www.cycif.org/data/pca-2019/osd-3_cycif</a></p>
    <ul>
      <li>MART1 in groups: architecure panel, Progression, Immune</li>
      <li>pan-Cytokeratin in groups: architecure panel, Progression</li>
      <li>CD163 in groups: architecure panel, Immune</li>
      <li>CD3D in groups: architecure panel, Immune</li>
    </ul>
    <h2>pca-2019/osd-1_cycif</h2>
    <p><a href="https://www.cycif.org/data/pca-2019/osd-1_cycif">https://www.cycif.org/data/pca-2019/osd-1_cycif</a></p>
    <ul>
      <li>MART1 in groups: Architecure panel, Progression, Immune</li>
      <li>pan-Cytokeratin in groups: Architecure panel, Progression</li>
      <li>CD163 in groups: Architecure panel, Immune, PDL1-Macrophage</li>
      <li>CD3D in groups: Architecure panel, T Cells, Immune, PDL1-T cells</li>
      <li>PDL1 in groups: Progression, PDL1-T cells, PDL1-Macrophage</li>
    </ul>
    <h2>https://www.cycif.org/pca-2019/osd-z136_1</h2>
    <p><a href="https://www.cycif.org/pca-2019/osd-z136_1">https://www.cycif.org/pca-2019/osd-z136_1</a></p>
    <ul>
      <li>CD3E in groups: Tissue Architecture, T-cells Regulation</li>
      <li>KERATIN in groups: Tissue Architecture, Subcellular Architecture</li>
      <li>CD163 in groups: Tissue Architecture, Macrophage</li>
    </ul>
    <h2>pca-2019/osd-2_cycif</h2>
    <p><a href="https://www.cycif.org/data/pca-2019/osd-2_cycif">https://www.cycif.org/data/pca-2019/osd-2_cycif</a></p>
    <ul>
      <li>MART1 in groups: Architecure panel, T Cells, PDL1-Tumor</li>
      <li>CD163 in groups: Architecure panel, PDL1-Macrophages</li>
      <li>CD3D in groups: Architecure panel, PDL1-T Cells</li>
      <li>PDL1 in groups: PDL1-Tumor, PDL1-T Cells, PDL1-Macrophages</li>
    </ul>
    <h2>gaglia-PCQ-2020/osd-0813</h2>
    <p><a href="https://www.cycif.org/data/gaglia-PCQ-2020/osd-0813">https://www.cycif.org/data/gaglia-PCQ-2020/osd-0813</a></p>
    <ul>
      <li>e-Cadherin in groups: Cell Type, Proliferation, Arrest, Proliferation and Arrest, Cell Cycle, e-Cadherin</li>
      <li>CD45 in groups: Cell Type, CD45</li>
      <li>Vimentin in groups: Cell Type, Vimentin</li>
      <li>aSMA in groups: Cell Type, aSMA</li>
      <li>PCNA in groups: Proliferation, Proliferation and Arrest, PCNA</li>
      <li>MCM2 in groups: Proliferation, Proliferation and Arrest, MCM2</li>
      <li>Ki67 in groups: Proliferation, Proliferation and Arrest, Ki67 - Cell Signaling Technology AF488, Ki67 - Biolegend AF555</li>
      <li>p21 in groups: Arrest, Proliferation and Arrest, p21</li>
      <li>p27 in groups: Arrest, Proliferation and Arrest, p27</li>
      <li>CDT1 in groups: Cell Cycle, CDT1</li>
      <li>CCNE1 in groups: Cell Cycle, Cyclin E1</li>
      <li>Geminin in groups: Cell Cycle, Geminin</li>
      <li>pRB in groups: Cell Cycle, pRB</li>
      <li>pHH3 in groups: Cell Cycle, pHH3</li>
    </ul>
    <h2>lin-chen-campton-2022/P37_S57-CRC08</h2>
    <p><a href="lin-chen-campton-2022/P37_S57-CRC08">lin-chen-campton-2022/P37_S57-CRC08</a></p>
    <ul>
      <li>CD31 in groups: Overview, Autofluorescence</li>
      <li>Î±-SMA in groups: Overview, Autofluorescence</li>
    </ul>
    <h2>lin-chen-campton-2022/P37_S38-CRC10</h2>
    <p><a href="lin-chen-campton-2022/P37_S38-CRC10">lin-chen-campton-2022/P37_S38-CRC10</a></p>
    <ul>
      <li>CD31 in groups: Overview, Autofluorescence</li>
      <li>Î±-SMA in groups: Overview, Autofluorescence</li>
    </ul>
    <h2>lin-chen-campton-2022/P37_S66-CRC29</h2>
    <p><a href="lin-chen-campton-2022/P37_S66-CRC29">lin-chen-campton-2022/P37_S66-CRC29</a></p>
    <ul>
      <li>CD31 in groups: Overview, Autofluorescence</li>
      <li>Î±-SMA in groups: Overview, Autofluorescence</li>
    </ul>
    <h2>lin-chen-campton-2022/P37_S76_01-CRC33_01</h2>
    <p><a href="lin-chen-campton-2022/P37_S76_01-CRC33_01">lin-chen-campton-2022/P37_S76_01-CRC33_01</a></p>
    <ul>
      <li>CD31 in groups: Overview, Autofluorescence</li>
      <li>Î±-SMA in groups: Overview, Autofluorescence</li>
    </ul>
    <h2>lin-chen-campton-2022/P37_S34-CRC06</h2>
    <p><a href="lin-chen-campton-2022/P37_S34-CRC06">lin-chen-campton-2022/P37_S34-CRC06</a></p>
    <ul>
      <li>CD31 in groups: Overview, Autofluorescence</li>
      <li>Î±-SMA in groups: Overview, Autofluorescence</li>
    </ul>
    <h2>lin-chen-campton-2022/P37_S64-CRC27</h2>
    <p><a href="lin-chen-campton-2022/P37_S64-CRC27">lin-chen-campton-2022/P37_S64-CRC27</a></p>
    <ul>
      <li>CD31 in groups: Overview, Autofluorescence</li>
      <li>Î±-SMA in groups: Overview, Autofluorescence</li>
    </ul>
    <h2>lin-chen-campton-2022/P37_S78-CRC35</h2>
    <p><a href="lin-chen-campton-2022/P37_S78-CRC35">lin-chen-campton-2022/P37_S78-CRC35</a></p>
    <ul>
      <li>CD31 in groups: Overview, Autofluorescence</li>
      <li>Î±-SMA in groups: Overview, Autofluorescence</li>
    </ul>
    <h2>lin-chen-campton-2022/P37_S29-CRC01</h2>
    <p><a href="lin-chen-campton-2022/P37_S29-CRC01">lin-chen-campton-2022/P37_S29-CRC01</a></p>
    <ul>
      <li>CD31 in groups: Overview, Autofluorescence</li>
      <li>Î±-SMA in groups: Overview, Autofluorescence</li>
    </ul>
    <h2>lin-chen-campton-2022/P37_S76_02-CRC33_02</h2>
    <p><a href="lin-chen-campton-2022/P37_S76_02-CRC33_02">lin-chen-campton-2022/P37_S76_02-CRC33_02</a></p>
    <ul>
      <li>CD31 in groups: Overview, Autofluorescence</li>
      <li>Î±-SMA in groups: Overview, Autofluorescence</li>
    </ul>
    <h2>lin-chen-campton-2022/P37_S37-CRC09</h2>
    <p><a href="lin-chen-campton-2022/P37_S37-CRC09">lin-chen-campton-2022/P37_S37-CRC09</a></p>
    <ul>
      <li>CD31 in groups: Overview, Autofluorescence</li>
      <li>Î±-SMA in groups: Overview, Autofluorescence</li>
    </ul>
    <h2>lin-chen-campton-2022/P37_S65-CRC28</h2>
    <p><a href="lin-chen-campton-2022/P37_S65-CRC28">lin-chen-campton-2022/P37_S65-CRC28</a></p>
    <ul>
      <li>CD31 in groups: Overview, Autofluorescence</li>
      <li>Î±-SMA in groups: Overview, Autofluorescence</li>
    </ul>
    <h2>lin-chen-campton-2022/P37_S58-CRC21</h2>
    <p><a href="lin-chen-campton-2022/P37_S58-CRC21">lin-chen-campton-2022/P37_S58-CRC21</a></p>
    <ul>
      <li>CD31 in groups: Overview, Autofluorescence</li>
      <li>Î±-SMA in groups: Overview, Autofluorescence</li>
    </ul>
    <h2>lin-chen-campton-2022/P37_S35-CRC07</h2>
    <p><a href="lin-chen-campton-2022/P37_S35-CRC07">lin-chen-campton-2022/P37_S35-CRC07</a></p>
    <ul>
      <li>CD31 in groups: Overview, Autofluorescence</li>
      <li>Î±-SMA in groups: Overview, Autofluorescence</li>
    </ul>
    <h2>lin-chen-campton-2022/P37_S43-CRC11</h2>
    <p><a href="lin-chen-campton-2022/P37_S43-CRC11">lin-chen-campton-2022/P37_S43-CRC11</a></p>
    <ul>
      <li>CD31 in groups: Overview, Autofluorescence</li>
      <li>Î±-SMA in groups: Overview, Autofluorescence</li>
    </ul>
    <h2>lin-chen-campton-2022/P37_S74-CRC31</h2>
    <p><a href="lin-chen-campton-2022/P37_S74-CRC31">lin-chen-campton-2022/P37_S74-CRC31</a></p>
    <ul>
      <li>CD31 in groups: Overview, Autofluorescence</li>
      <li>Î±-SMA in groups: Overview, Autofluorescence</li>
    </ul>
    <h2>lin-chen-campton-2022/P37_S63-CRC26</h2>
    <p><a href="lin-chen-campton-2022/P37_S63-CRC26">lin-chen-campton-2022/P37_S63-CRC26</a></p>
    <ul>
      <li>CD31 in groups: Overview, Autofluorescence</li>
      <li>Î±-SMA in groups: Overview, Autofluorescence</li>
    </ul>
    <h2>lin-chen-campton-2022/P37_S50-CRC18</h2>
    <p><a href="lin-chen-campton-2022/P37_S50-CRC18">lin-chen-campton-2022/P37_S50-CRC18</a></p>
    <ul>
      <li>CD31 in groups: Overview, Autofluorescence</li>
      <li>Î±-SMA in groups: Overview, Autofluorescence</li>
    </ul>
    <h2>lin-chen-campton-2022/P37_S59-CRC22</h2>
    <p><a href="lin-chen-campton-2022/P37_S59-CRC22">lin-chen-campton-2022/P37_S59-CRC22</a></p>
    <ul>
      <li>CD31 in groups: Overview, Autofluorescence</li>
      <li>Î±-SMA in groups: Overview, Autofluorescence</li>
    </ul>
    <h2>lin-chen-campton-2022/P37_S49-CRC17</h2>
    <p><a href="lin-chen-campton-2022/P37_S49-CRC17">lin-chen-campton-2022/P37_S49-CRC17</a></p>
    <ul>
      <li>CD31 in groups: Overview, Autofluorescence</li>
      <li>Î±-SMA in groups: Overview, Autofluorescence</li>
    </ul>
    <h2>lin-chen-campton-2022/P37_S52-CRC20</h2>
    <p><a href="lin-chen-campton-2022/P37_S52-CRC20">lin-chen-campton-2022/P37_S52-CRC20</a></p>
    <ul>
      <li>CD31 in groups: Overview, Autofluorescence</li>
      <li>Î±-SMA in groups: Overview, Autofluorescence</li>
    </ul>
    <h2>lin-chen-campton-2022/P37_S46-CRC14</h2>
    <p><a href="lin-chen-campton-2022/P37_S46-CRC14">lin-chen-campton-2022/P37_S46-CRC14</a></p>
    <ul>
      <li>CD31 in groups: Overview, Autofluorescence</li>
      <li>Î±-SMA in groups: Overview, Autofluorescence</li>
    </ul>
    <h2>lin-chen-campton-2022/P37_S60-CRC23</h2>
    <p><a href="lin-chen-campton-2022/P37_S60-CRC23">lin-chen-campton-2022/P37_S60-CRC23</a></p>
    <ul>
      <li>CD31 in groups: Overview, Autofluorescence</li>
      <li>Î±-SMA in groups: Overview, Autofluorescence</li>
    </ul>
    <h2>lin-chen-campton-2022/P37_S30-CRC02</h2>
    <p><a href="lin-chen-campton-2022/P37_S30-CRC02">lin-chen-campton-2022/P37_S30-CRC02</a></p>
    <ul>
      <li>CD31 in groups: Overview, Autofluorescence</li>
      <li>Î±-SMA in groups: Overview, Autofluorescence</li>
    </ul>
    <h2>lin-chen-campton-2022/P37_S81-CRC38</h2>
    <p><a href="lin-chen-campton-2022/P37_S81-CRC38">lin-chen-campton-2022/P37_S81-CRC38</a></p>
    <ul>
      <li>CD31 in groups: Overview, Autofluorescence</li>
      <li>Î±-SMA in groups: Overview, Autofluorescence</li>
    </ul>
    <h2>lin-chen-campton-2022/P37_S62-CRC25</h2>
    <p><a href="lin-chen-campton-2022/P37_S62-CRC25">lin-chen-campton-2022/P37_S62-CRC25</a></p>
    <ul>
      <li>CD31 in groups: Overview, Autofluorescence</li>
      <li>Î±-SMA in groups: Overview, Autofluorescence</li>
    </ul>
    <h2>lin-chen-campton-2022/P37_S44-CRC12</h2>
    <p><a href="lin-chen-campton-2022/P37_S44-CRC12">lin-chen-campton-2022/P37_S44-CRC12</a></p>
    <ul>
      <li>CD31 in groups: Overview, Autofluorescence</li>
      <li>Î±-SMA in groups: Overview, Autofluorescence</li>
    </ul>
    <h2>lin-chen-campton-2022/P37_S67-CRC30</h2>
    <p><a href="lin-chen-campton-2022/P37_S67-CRC30">lin-chen-campton-2022/P37_S67-CRC30</a></p>
    <ul>
      <li>CD31 in groups: Overview, Autofluorescence</li>
      <li>Î±-SMA in groups: Overview, Autofluorescence</li>
    </ul>
    <h2>lin-chen-campton-2022/P37_S32-CRC04</h2>
    <p><a href="lin-chen-campton-2022/P37_S32-CRC04">lin-chen-campton-2022/P37_S32-CRC04</a></p>
    <ul>
      <li>CD31 in groups: Overview, Autofluorescence</li>
      <li>Î±-SMA in groups: Overview, Autofluorescence</li>
    </ul>
    <h2>lin-chen-campton-2022/P37_S75-CRC32</h2>
    <p><a href="lin-chen-campton-2022/P37_S75-CRC32">lin-chen-campton-2022/P37_S75-CRC32</a></p>
    <ul>
      <li>CD31 in groups: Overview, Autofluorescence</li>
      <li>Î±-SMA in groups: Overview, Autofluorescence</li>
    </ul>
    <h2>lin-chen-campton-2022/P37_S77-CRC34</h2>
    <p><a href="lin-chen-campton-2022/P37_S77-CRC34">lin-chen-campton-2022/P37_S77-CRC34</a></p>
    <ul>
      <li>CD31 in groups: Overview, Autofluorescence</li>
      <li>Î±-SMA in groups: Overview, Autofluorescence</li>
    </ul>
    <h2>lin-chen-campton-2022/P37_S79-CRC36</h2>
    <p><a href="lin-chen-campton-2022/P37_S79-CRC36">lin-chen-campton-2022/P37_S79-CRC36</a></p>
    <ul>
      <li>CD31 in groups: Overview, Autofluorescence</li>
      <li>Î±-SMA in groups: Overview, Autofluorescence</li>
    </ul>
    <h2>lin-chen-campton-2022/P37_S51-CRC19</h2>
    <p><a href="lin-chen-campton-2022/P37_S51-CRC19">lin-chen-campton-2022/P37_S51-CRC19</a></p>
    <ul>
      <li>CD31 in groups: Overview, Autofluorescence</li>
      <li>Î±-SMA in groups: Overview, Autofluorescence</li>
    </ul>
    <h2>lin-chen-campton-2022/P37_S83-CRC40</h2>
    <p><a href="lin-chen-campton-2022/P37_S83-CRC40">lin-chen-campton-2022/P37_S83-CRC40</a></p>
    <ul>
      <li>CD31 in groups: Overview, Autofluorescence</li>
      <li>Î±-SMA in groups: Overview, Autofluorescence</li>
    </ul>
    <h2>lin-chen-campton-2022/P37_S48-CRC16</h2>
    <p><a href="lin-chen-campton-2022/P37_S48-CRC16">lin-chen-campton-2022/P37_S48-CRC16</a></p>
    <ul>
      <li>CD31 in groups: Overview, Autofluorescence</li>
      <li>Î±-SMA in groups: Overview, Autofluorescence</li>
    </ul>
    <h2>lin-chen-campton-2022/P37_S47-CRC15</h2>
    <p><a href="lin-chen-campton-2022/P37_S47-CRC15">lin-chen-campton-2022/P37_S47-CRC15</a></p>
    <ul>
      <li>CD31 in groups: Overview, Autofluorescence</li>
      <li>Î±-SMA in groups: Overview, Autofluorescence</li>
    </ul>
    <h2>lin-chen-campton-2022/P37_S31-CRC03</h2>
    <p><a href="lin-chen-campton-2022/P37_S31-CRC03">lin-chen-campton-2022/P37_S31-CRC03</a></p>
    <ul>
      <li>CD31 in groups: Overview, Autofluorescence</li>
      <li>Î±-SMA in groups: Overview, Autofluorescence</li>
    </ul>
    <h2>lin-chen-campton-2022/P37_S45-CRC13</h2>
    <p><a href="lin-chen-campton-2022/P37_S45-CRC13">lin-chen-campton-2022/P37_S45-CRC13</a></p>
    <ul>
      <li>CD31 in groups: Overview, Autofluorescence</li>
      <li>Î±-SMA in groups: Overview, Autofluorescence</li>
    </ul>
    <h2>lin-chen-campton-2022/P37_S80-CRC37</h2>
    <p><a href="lin-chen-campton-2022/P37_S80-CRC37">lin-chen-campton-2022/P37_S80-CRC37</a></p>
    <ul>
      <li>CD31 in groups: Overview, Autofluorescence</li>
      <li>Î±-SMA in groups: Overview, Autofluorescence</li>
    </ul>
    <h2>lin-chen-campton-2022/P37_S33-CRC05</h2>
    <p><a href="lin-chen-campton-2022/P37_S33-CRC05">lin-chen-campton-2022/P37_S33-CRC05</a></p>
    <ul>
      <li>CD31 in groups: Overview, Autofluorescence</li>
      <li>Î±-SMA in groups: Overview, Autofluorescence</li>
    </ul>
    <h2>lin-chen-campton-2022/P37_S61-CRC24</h2>
    <p><a href="lin-chen-campton-2022/P37_S61-CRC24">lin-chen-campton-2022/P37_S61-CRC24</a></p>
    <ul>
      <li>CD31 in groups: Overview, Autofluorescence</li>
      <li>Î±-SMA in groups: Overview, Autofluorescence</li>
    </ul>
    <h2>lin-chen-campton-2022/P37_S82-CRC39</h2>
    <p><a href="lin-chen-campton-2022/P37_S82-CRC39">lin-chen-campton-2022/P37_S82-CRC39</a></p>
    <ul>
      <li>CD31 in groups: Overview, Autofluorescence</li>
      <li>Î±-SMA in groups: Overview, Autofluorescence</li>
    </ul>
    <h2>tnp-2020/osd-crc-case-1-ffpe-cycif</h2>
    <p><a href="https://www.cycif.org/data/tnp-2020/osd-crc-case-1-ffpe-cycif">https://www.cycif.org/data/tnp-2020/osd-crc-case-1-ffpe-cycif</a></p>
    <ul>
      <li>Ki67 in groups: Cycle 3, Cycle 9</li>
    </ul>
    <h2>pca-2020/osd-PCA_Z136_10b</h2>
    <p><a href="https://www.cycif.org/data/pca-2020/osd-PCA_Z136_10b">https://www.cycif.org/data/pca-2020/osd-PCA_Z136_10b</a></p>
    <ul>
      <li>Melanocyte-SOX10 in groups: Main Lineage Markers, T-Cell Markers</li>
      <li>T-Lymphocyte-CD3E in groups: Main Lineage Markers, T-Cell Markers</li>
      <li>T-Lymphocyte-CD3D in groups: Main Lineage Markers, T-Cell Markers</li>
      <li>T-Lymphocyte in groups: T-Cell Co-Stimulation, T-Cell Co-Stimulation, T-Cell Co-Stimulation Cont_, T-Cell Co-Stimulation Cont_</li>
      <li>LAG3 in groups: T-Cell Co-Stimulation, T-Cell Co-Stimulation</li>
      <li>KERATIN in groups: T-Cell Co-Stimulation, T-Cell Co-Stimulation Cont_</li>
    </ul>
    <h2>gross-2022</h2>
    <p><a href="gross-2022">gross-2022</a></p>
    <ul>
      <li>empty in groups: Cycle 8, Cycle 9</li>
    </ul>
    <h2>wu-temko-maliga-2022/P137941</h2>
    <p><a href="wu-temko-maliga-2022/P137941">wu-temko-maliga-2022/P137941</a></p>
    <ul>
      <li>KERATIN in groups: Tissue Architecture, Tumor, Proliferation</li>
      <li>CD45 in groups: Tissue Architecture, Proliferation</li>
      <li>KI67 in groups: Tumor, Proliferation</li>
      <li>CMA1 in groups: Immune, Myeloid</li>
      <li>CD3D in groups: Immune, Lymphoid</li>
      <li>CD163 in groups: Immune, Myeloid</li>
      <li>CD20 in groups: Immune, Lymphoid</li>
      <li>CD8A in groups: Lymphoid, T cell activation</li>
      <li>CD4 in groups: Lymphoid, T cell activation</li>
    </ul>
    <h2>wu-temko-maliga-2022/P132666</h2>
    <p><a href="wu-temko-maliga-2022/P132666">wu-temko-maliga-2022/P132666</a></p>
    <ul>
      <li>KERATIN in groups: Tissue Architecture, Tumor, Proliferation</li>
      <li>CD45 in groups: Tissue Architecture, Proliferation</li>
      <li>KI67 in groups: Tumor, Proliferation</li>
      <li>CMA1 in groups: Immune, Myeloid</li>
      <li>CD3D in groups: Immune, Lymphoid</li>
      <li>CD163 in groups: Immune, Myeloid</li>
      <li>CD20 in groups: Immune, Lymphoid</li>
      <li>CD8A in groups: Lymphoid, T cell activation</li>
      <li>CD4 in groups: Lymphoid, T cell activation</li>
    </ul>
    <h2>wu-temko-maliga-2022/P137753</h2>
    <p><a href="wu-temko-maliga-2022/P137753">wu-temko-maliga-2022/P137753</a></p>
    <ul>
      <li>KERATIN in groups: Tissue Architecture, Tumor, Proliferation</li>
      <li>CD45 in groups: Tissue Architecture, Proliferation</li>
      <li>KI67 in groups: Tumor, Proliferation</li>
      <li>CMA1 in groups: Immune, Myeloid</li>
      <li>CD3D in groups: Immune, Lymphoid</li>
      <li>CD163 in groups: Immune, Myeloid</li>
      <li>CD20 in groups: Immune, Lymphoid</li>
      <li>CD8A in groups: Lymphoid, T cell activation</li>
      <li>CD4 in groups: Lymphoid, T cell activation</li>
    </ul>
    <h2>wu-temko-maliga-2022/P138007</h2>
    <p><a href="wu-temko-maliga-2022/P138007">wu-temko-maliga-2022/P138007</a></p>
    <ul>
      <li>KERATIN in groups: Tissue Architecture, Tumor, Proliferation</li>
      <li>CD45 in groups: Tissue Architecture, Proliferation</li>
      <li>KI67 in groups: Tumor, Proliferation</li>
      <li>CMA1 in groups: Immune, Myeloid</li>
      <li>CD3D in groups: Immune, Lymphoid</li>
      <li>CD163 in groups: Immune, Myeloid</li>
      <li>CD20 in groups: Immune, Lymphoid</li>
      <li>CD8A in groups: Lymphoid, T cell activation</li>
      <li>CD4 in groups: Lymphoid, T cell activation</li>
    </ul>
    <h2>wu-temko-maliga-2022/P132115</h2>
    <p><a href="wu-temko-maliga-2022/P132115">wu-temko-maliga-2022/P132115</a></p>
    <ul>
      <li>KERATIN in groups: Tissue Architecture, Tumor, Proliferation</li>
      <li>CD45 in groups: Tissue Architecture, Proliferation</li>
      <li>KI67 in groups: Tumor, Proliferation</li>
      <li>CMA1 in groups: Immune, Myeloid</li>
      <li>CD3D in groups: Immune, Lymphoid</li>
      <li>CD163 in groups: Immune, Myeloid</li>
      <li>CD20 in groups: Immune, Lymphoid</li>
      <li>CD8A in groups: Lymphoid, T cell activation</li>
      <li>CD4 in groups: Lymphoid, T cell activation</li>
    </ul>
    <h2>wu-temko-maliga-2022/P137974</h2>
    <p><a href="wu-temko-maliga-2022/P137974">wu-temko-maliga-2022/P137974</a></p>
    <ul>
      <li>KERATIN in groups: Tissue Architecture, Tumor, Proliferation</li>
      <li>CD45 in groups: Tissue Architecture, Proliferation</li>
      <li>KI67 in groups: Tumor, Proliferation</li>
      <li>CMA1 in groups: Immune, Myeloid</li>
      <li>CD3D in groups: Immune, Lymphoid</li>
      <li>CD163 in groups: Immune, Myeloid</li>
      <li>CD20 in groups: Immune, Lymphoid</li>
      <li>CD8A in groups: Lymphoid, T cell activation</li>
      <li>CD4 in groups: Lymphoid, T cell activation</li>
    </ul>
    <h2>wu-temko-maliga-2022/P132630</h2>
    <p><a href="wu-temko-maliga-2022/P132630">wu-temko-maliga-2022/P132630</a></p>
    <ul>
      <li>KERATIN in groups: Tissue Architecture, Tumor, Proliferation</li>
      <li>CD45 in groups: Tissue Architecture, Proliferation</li>
      <li>KI67 in groups: Tumor, Proliferation</li>
      <li>CMA1 in groups: Immune, Myeloid</li>
      <li>CD3D in groups: Immune, Lymphoid</li>
      <li>CD163 in groups: Immune, Myeloid</li>
      <li>CD20 in groups: Immune, Lymphoid</li>
      <li>CD8A in groups: Lymphoid, T cell activation</li>
      <li>CD4 in groups: Lymphoid, T cell activation</li>
    </ul>
    <h2>wu-temko-maliga-2022/P136690</h2>
    <p><a href="wu-temko-maliga-2022/P136690">wu-temko-maliga-2022/P136690</a></p>
    <ul>
      <li>KERATIN in groups: Tissue Architecture, Tumor, Proliferation</li>
      <li>CD45 in groups: Tissue Architecture, Proliferation</li>
      <li>KI67 in groups: Tumor, Proliferation</li>
      <li>CMA1 in groups: Immune, Myeloid</li>
      <li>CD3D in groups: Immune, Lymphoid</li>
      <li>CD163 in groups: Immune, Myeloid</li>
      <li>CD20 in groups: Immune, Lymphoid</li>
      <li>CD8A in groups: Lymphoid, T cell activation</li>
      <li>CD4 in groups: Lymphoid, T cell activation</li>
    </ul>
    <h2>wu-temko-maliga-2022/P137757</h2>
    <p><a href="wu-temko-maliga-2022/P137757">wu-temko-maliga-2022/P137757</a></p>
    <ul>
      <li>KERATIN in groups: Tissue Architecture, Tumor, Proliferation</li>
      <li>CD45 in groups: Tissue Architecture, Proliferation</li>
      <li>KI67 in groups: Tumor, Proliferation</li>
      <li>CMA1 in groups: Immune, Myeloid</li>
      <li>CD3D in groups: Immune, Lymphoid</li>
      <li>CD163 in groups: Immune, Myeloid</li>
      <li>CD20 in groups: Immune, Lymphoid</li>
      <li>CD8A in groups: Lymphoid, T cell activation</li>
      <li>CD4 in groups: Lymphoid, T cell activation</li>
    </ul>
    <h2>wu-temko-maliga-2022/P137591</h2>
    <p><a href="wu-temko-maliga-2022/P137591">wu-temko-maliga-2022/P137591</a></p>
    <ul>
      <li>KERATIN in groups: Tissue Architecture, Tumor, Proliferation</li>
      <li>CD45 in groups: Tissue Architecture, Proliferation</li>
      <li>KI67 in groups: Tumor, Proliferation</li>
      <li>CMA1 in groups: Immune, Myeloid</li>
      <li>CD3D in groups: Immune, Lymphoid</li>
      <li>CD163 in groups: Immune, Myeloid</li>
      <li>CD20 in groups: Immune, Lymphoid</li>
      <li>CD8A in groups: Lymphoid, T cell activation</li>
      <li>CD4 in groups: Lymphoid, T cell activation</li>
    </ul>
    <h2>wu-temko-maliga-2022/P137905</h2>
    <p><a href="wu-temko-maliga-2022/P137905">wu-temko-maliga-2022/P137905</a></p>
    <ul>
      <li>KERATIN in groups: Tissue Architecture, Tumor, Proliferation</li>
      <li>CD45 in groups: Tissue Architecture, Proliferation</li>
      <li>KI67 in groups: Tumor, Proliferation</li>
      <li>CMA1 in groups: Immune, Myeloid</li>
      <li>CD3D in groups: Immune, Lymphoid</li>
      <li>CD163 in groups: Immune, Myeloid</li>
      <li>CD20 in groups: Immune, Lymphoid</li>
      <li>CD8A in groups: Lymphoid, T cell activation</li>
      <li>CD4 in groups: Lymphoid, T cell activation</li>
    </ul>
    <h2>wu-temko-maliga-2022/P133537</h2>
    <p><a href="wu-temko-maliga-2022/P133537">wu-temko-maliga-2022/P133537</a></p>
    <ul>
      <li>KERATIN in groups: Tissue Architecture, Tumor, Proliferation</li>
      <li>CD45 in groups: Tissue Architecture, Proliferation</li>
      <li>KI67 in groups: Tumor, Proliferation</li>
      <li>CMA1 in groups: Immune, Myeloid</li>
      <li>CD3D in groups: Immune, Lymphoid</li>
      <li>CD163 in groups: Immune, Myeloid</li>
      <li>CD20 in groups: Immune, Lymphoid</li>
      <li>CD8A in groups: Lymphoid, T cell activation</li>
      <li>CD4 in groups: Lymphoid, T cell activation</li>
    </ul>
    <h2>lin-elife-2018/osd-figure2</h2>
    <p><a href="https://www.cycif.org/data/lin-elife-2018/osd-figure2">https://www.cycif.org/data/lin-elife-2018/osd-figure2</a></p>
    <ul>
      <li>CD3 in groups: T-Cells, PD-1/PD-L1</li>
    </ul>
    <h2>nirmal-vallius-maliga-2021/viz</h2>
    <p><a href="https://www.cycif.org/data/nirmal-vallius-maliga-2021/viz">https://www.cycif.org/data/nirmal-vallius-maliga-2021/viz</a></p>
    <ul>
      <li>CD3D in groups: Tissue architecture MIS, Single-cell phenotyping, Tissue architecture IM, Tissue architecture EM</li>
      <li>CD11C in groups: Tissue architecture MIS, Single-cell phenotyping, Tissue architecture IM, Tissue architecture EM, Cell to cell interactions, Immune suppression, Intratumor heterogeneity</li>
      <li>Pan-CK in groups: Tissue architecture MIS, Tissue architecture, Cytotoxic T cells MIS, Tumor clusters</li>
      <li>SOX10 in groups: Tissue architecture MIS, T cell exhaustion, MHC-II-high cluster T5a, CCND1-high cluster T5b, Tissue architecture, Tissue architecture IM, Tissue architecture EM, Cytotoxic T cells MIS, Cell to cell interactions, Immune suppression, Immune editing, Intratumor heterogeneity</li>
      <li>CD8A in groups: Single-cell phenotyping, T cell exhaustion, Cytotoxic T cells MIS, Cell to cell interactions, Immune suppression, Immune editing, Intratumor heterogeneity</li>
      <li>PDL1 in groups: Single-cell phenotyping, Cell to cell interactions, Immune suppression, Intratumor heterogeneity</li>
      <li>LAG3 in groups: T cell exhaustion, Cytotoxic T cells MIS</li>
      <li>PD1 in groups: T cell exhaustion, Cytotoxic T cells MIS, Immune editing</li>
      <li>TIM3 in groups: T cell exhaustion, Cytotoxic T cells MIS, Cell to cell interactions, Immune editing, Intratumor heterogeneity</li>
      <li>aSMA in groups: Tissue architecture, Tissue architecture IM, Tissue architecture EM</li>
      <li>CD31 in groups: Tissue architecture, Tissue architecture IM, Tissue architecture EM</li>
    </ul>
    <h2>du-lin-rashid-nat-protoc-2019/osd-LUNG_3</h2>
    <p><a href="https://www.cycif.org/data/du-lin-rashid-nat-protoc-2019/osd-LUNG_3">https://www.cycif.org/data/du-lin-rashid-nat-protoc-2019/osd-LUNG_3</a></p>
    <ul>
      <li>Keratin in groups: Structural Components, PD-L1 Expression</li>
      <li>CD45 in groups: Structural Components, CD45</li>
      <li>IBA1 in groups: Structural Components, PD-L1 Expression, Macrophages, IBA1</li>
      <li>CD3d in groups: Lymphocytes, Regulatory T-Cells, Cytotoxic T-Cells, Inhibitory T-Cells, CD3d</li>
      <li>CD20 in groups: Lymphocytes, CD20</li>
      <li>CD4 in groups: Regulatory T-Cells, CD8+/FOXP3+ T Cells, PD1+/LAG3+ T Cells, CD4</li>
      <li>FOXP3 in groups: Regulatory T-Cells, Inhibitory T-Cells, CD8+/FOXP3+ T Cells, FOXP3</li>
      <li>PD1 in groups: Inhibitory T-Cells, PD1+/LAG3+ T Cells, PD1</li>
      <li>CD8A in groups: CD8+/FOXP3+ T Cells, PD1+/LAG3+ T Cells, CD8A</li>
      <li>LAG3 in groups: PD1+/LAG3+ T Cells, LAG3</li>
      <li>CD163 in groups: Macrophages, CD163</li>
      <li>CD68 in groups: Macrophages (cont.), CD68</li>
      <li>CD11B in groups: Macrophages (cont.), CD11B</li>
      <li>CD14 in groups: Macrophages (cont.), CD14_27__CD14</li>
    </ul>
    <h2>du-lin-rashid-nat-protoc-2019/osd-LUNG_2</h2>
    <p><a href="https://www.cycif.org/data/du-lin-rashid-nat-protoc-2019/osd-LUNG_2">https://www.cycif.org/data/du-lin-rashid-nat-protoc-2019/osd-LUNG_2</a></p>
    <ul>
      <li>IBA1 in groups: Structural Components, Macrophages</li>
    </ul>
    <h2>du-lin-rashid-nat-protoc-2019/osd-TONSIL_1</h2>
    <p><a href="https://www.cycif.org/data/du-lin-rashid-nat-protoc-2019/osd-TONSIL_1">https://www.cycif.org/data/du-lin-rashid-nat-protoc-2019/osd-TONSIL_1</a></p>
    <ul>
      <li>IBA1 in groups: Structural Components, Macrophages</li>
      <li>CD3D in groups: Lymphocytes, Helper and Cytotoxic T-Cells</li>
    </ul>
    <h2>du-lin-rashid-nat-protoc-2019/osd-LUNG_1</h2>
    <p><a href="https://www.cycif.org/data/du-lin-rashid-nat-protoc-2019/osd-LUNG_1">https://www.cycif.org/data/du-lin-rashid-nat-protoc-2019/osd-LUNG_1</a></p>
    <ul>
      <li>IBA1 in groups: Structural Components, Macrophages</li>
    </ul>
    <h2>du-lin-rashid-nat-protoc-2019/osd-TONSIL_IHC</h2>
    <p><a href="https://www.cycif.org/data/du-lin-rashid-nat-protoc-2019/osd-TONSIL_IHC">https://www.cycif.org/data/du-lin-rashid-nat-protoc-2019/osd-TONSIL_IHC</a></p>
    <ul>
      <li>CD4 in groups: CD4, IF - CD4, CD3D, CD8A</li>
      <li>CD20 in groups: CD20, IF - CD20, CD3D</li>
      <li>CD68 in groups: CD68, IF - CD68</li>
      <li>CD3D in groups: IF - CD20, CD3D, IF - CD4, CD3D, CD8A</li>
    </ul>
    <h2>lin-wang-coy-2021/overview</h2>
    <p><a href="https://www.cycif.org/data/lin-wang-coy-2021/overview">https://www.cycif.org/data/lin-wang-coy-2021/overview</a></p>
    <ul>
      <li>PanCK in groups: Tissue Structure, Proliferation, PD1 Immune Checkpoint, NaK ATPase, E-Cadherin, Tumor Budding Epithelial, Tumor Budding Immune Modulation, Transitions</li>
      <li>ASMA in groups: Tissue Structure, Stroma</li>
      <li>CD45 in groups: Tissue Structure, Immune Populations, Proliferation</li>
      <li>CD8a in groups: Immune Populations, Lymphocytes, CD8 Cytotoxic T Cells, FOXP3 CD8 T Cells, PDL1-CD8 Interaction, Tumor Budding Immune Modulation</li>
      <li>CD4 in groups: Immune Populations, Lymphocytes, Helper and Regulatory T Cells, PDL1-Positive Immune Cells</li>
      <li>CD20 in groups: Immune Populations, Lymphocytes</li>
      <li>CD68 in groups: Immune Populations, Macrophages, PDL1-Positive Immune Cells, Tumor Budding Immune Modulation</li>
      <li>CD163 in groups: Immune Populations, Macrophages, PDL1-Positive Immune Cells</li>
      <li>FOXP3 in groups: Lymphocytes, Helper and Regulatory T Cells, FOXP3 CD8 T Cells, Tumor Budding Immune Modulation</li>
      <li>PCNA in groups: Proliferation, Tumor Budding Epithelial, Transitions</li>
      <li>PDL1 in groups: PD1 Immune Checkpoint, PDL1-Positive Immune Cells, PDL1-CD8 Interaction, Tumor Budding Immune Modulation</li>
      <li>PD1 in groups: PD1 Immune Checkpoint, CD8 Cytotoxic T Cells, PDL1-CD8 Interaction, Tumor Budding Immune Modulation</li>
      <li>Ecadherin in groups: E-Cadherin, Tumor Budding Epithelial, Transitions</li>
    </ul>
    <h2>lin-wang-coy-2021/all-channels/CRC10</h2>
    <p><a href="lin-wang-coy-2021/all-channels/CRC10">lin-wang-coy-2021/all-channels/CRC10</a></p>
    <ul>
      <li>Ki67 in groups: Cycle 3, Cycle 9</li>
    </ul>
    <h2>lin-wang-coy-2021/all-channels/CRC17</h2>
    <p><a href="lin-wang-coy-2021/all-channels/CRC17">lin-wang-coy-2021/all-channels/CRC17</a></p>
    <ul>
      <li>Ki67 in groups: Cycle 3, Cycle 9</li>
    </ul>
    <h2>lin-wang-coy-2021/all-channels/CRC16</h2>
    <p><a href="lin-wang-coy-2021/all-channels/CRC16">lin-wang-coy-2021/all-channels/CRC16</a></p>
    <ul>
      <li>Ki67 in groups: Cycle 3, Cycle 9</li>
    </ul>
    <h2>lin-wang-coy-2021/all-channels/CRC11</h2>
    <p><a href="lin-wang-coy-2021/all-channels/CRC11">lin-wang-coy-2021/all-channels/CRC11</a></p>
    <ul>
      <li>Ki67 in groups: Cycle 3, Cycle 9</li>
    </ul>
    <h2>lin-wang-coy-2021/all-channels/CRC02</h2>
    <p><a href="lin-wang-coy-2021/all-channels/CRC02">lin-wang-coy-2021/all-channels/CRC02</a></p>
    <ul>
      <li>Ki67 in groups: Cycle 3, Cycle 9</li>
    </ul>
    <h2>lin-wang-coy-2021/all-channels/CRC05</h2>
    <p><a href="lin-wang-coy-2021/all-channels/CRC05">lin-wang-coy-2021/all-channels/CRC05</a></p>
    <ul>
      <li>Ki67 in groups: Cycle 3, Cycle 9</li>
    </ul>
    <h2>lin-wang-coy-2021/all-channels/CRC04</h2>
    <p><a href="lin-wang-coy-2021/all-channels/CRC04">lin-wang-coy-2021/all-channels/CRC04</a></p>
    <ul>
      <li>Ki67 in groups: Cycle 3, Cycle 9</li>
    </ul>
    <h2>lin-wang-coy-2021/all-channels/CRC03</h2>
    <p><a href="lin-wang-coy-2021/all-channels/CRC03">lin-wang-coy-2021/all-channels/CRC03</a></p>
    <ul>
      <li>Ki67 in groups: Cycle 3, Cycle 9</li>
    </ul>
    <h2>lin-wang-coy-2021/all-channels/CRC14</h2>
    <p><a href="lin-wang-coy-2021/all-channels/CRC14">lin-wang-coy-2021/all-channels/CRC14</a></p>
    <ul>
      <li>Ki67 in groups: Cycle 3, Cycle 9</li>
    </ul>
    <h2>lin-wang-coy-2021/all-channels/CRC13</h2>
    <p><a href="lin-wang-coy-2021/all-channels/CRC13">lin-wang-coy-2021/all-channels/CRC13</a></p>
    <ul>
      <li>Ki67 in groups: Cycle 3, Cycle 9</li>
    </ul>
    <h2>lin-wang-coy-2021/all-channels/CRC12</h2>
    <p><a href="lin-wang-coy-2021/all-channels/CRC12">lin-wang-coy-2021/all-channels/CRC12</a></p>
    <ul>
      <li>Ki67 in groups: Cycle 3, Cycle 9</li>
    </ul>
    <h2>lin-wang-coy-2021/all-channels/CRC15</h2>
    <p><a href="lin-wang-coy-2021/all-channels/CRC15">lin-wang-coy-2021/all-channels/CRC15</a></p>
    <ul>
      <li>Ki67 in groups: Cycle 3, Cycle 9</li>
    </ul>
    <h2>lin-wang-coy-2021/all-channels/CRC06</h2>
    <p><a href="lin-wang-coy-2021/all-channels/CRC06">lin-wang-coy-2021/all-channels/CRC06</a></p>
    <ul>
      <li>Ki67 in groups: Cycle 3, Cycle 9</li>
    </ul>
    <h2>lin-wang-coy-2021/all-channels/CRC08</h2>
    <p><a href="lin-wang-coy-2021/all-channels/CRC08">lin-wang-coy-2021/all-channels/CRC08</a></p>
    <ul>
      <li>Ki67 in groups: Cycle 3, Cycle 9</li>
    </ul>
    <h2>lin-wang-coy-2021/all-channels/CRC09</h2>
    <p><a href="lin-wang-coy-2021/all-channels/CRC09">lin-wang-coy-2021/all-channels/CRC09</a></p>
    <ul>
      <li>Ki67 in groups: Cycle 3, Cycle 9</li>
    </ul>
    <h2>lin-wang-coy-2021/all-channels/CRC07</h2>
    <p><a href="lin-wang-coy-2021/all-channels/CRC07">lin-wang-coy-2021/all-channels/CRC07</a></p>
    <ul>
      <li>Ki67 in groups: Cycle 3, Cycle 9</li>
    </ul>
    <h2>lin-wang-coy-2021/viz</h2>
    <p><a href="https://www.cycif.org/data/lin-wang-coy-2021/viz">https://www.cycif.org/data/lin-wang-coy-2021/viz</a></p>
    <ul>
      <li>Pan-cytokeratin in groups: Overview 1, Immune supression, Tumor/Epi only, DNA + Pan-CK</li>
      <li>CD4 in groups: Overview 1, Immune supression</li>
      <li>E-cadherin in groups: Overview 2, Tumor/Epi only</li>
    </ul>
    <h2>tnp-2020/osd-crc-case-1-ffpe-cycif-pilot</h2>
    <p><a href="https://www.cycif.org/data/tnp-2020/osd-crc-case-1-ffpe-cycif-pilot">https://www.cycif.org/data/tnp-2020/osd-crc-case-1-ffpe-cycif-pilot</a></p>
    <ul>
      <li>Keratin in groups: Tissue Architecture, Immune, B-Cells and T-Cells, Proliferation, DNA Damage</li>
      <li>aSMA in groups: Tissue Architecture, Proliferation</li>
      <li>Ki67 in groups: Proliferation, Na+/K+ ATPase</li>
    </ul>
    <h2>tnp-2020/osd-crc-case-2-ffpe-mihc-pilot</h2>
    <p><a href="https://www.cycif.org/data/tnp-2020/osd-crc-case-2-ffpe-mihc-pilot">https://www.cycif.org/data/tnp-2020/osd-crc-case-2-ffpe-mihc-pilot</a></p>
    <ul>
      <li>CD3 in groups: Group 1, ASHLAR Group 1, Immune Cells, ASHLAR Immune Cells</li>
      <li>CD20 in groups: Group 1, ASHLAR Group 1</li>
      <li>FOXP3 in groups: Group 1, ASHLAR Group 1</li>
      <li>Ki67 in groups: Group 1, ASHLAR Group 1</li>
      <li>CD45 in groups: Immune Cells, ASHLAR Immune Cells</li>
    </ul>
    <h2>duraiswamy-2020/C0156</h2>
    <p><a href="duraiswamy-2020/C0156">duraiswamy-2020/C0156</a></p>
    <ul>
      <li>PD1 in groups: Functional Markers, T-cell-myeloid interaction</li>
      <li>pSTAT1 in groups: Functional Markers, T-cell-myeloid interaction</li>
      <li>CK7 in groups: Tumor-stroma, T-cell-myeloid interaction</li>
      <li>CD8a in groups: T-cells, T-cell-myeloid interaction</li>
      <li>CD11c in groups: Myeloid cells, T-cell-myeloid interaction</li>
    </ul>
    <h2>duraiswamy-2020/C0138</h2>
    <p><a href="duraiswamy-2020/C0138">duraiswamy-2020/C0138</a></p>
    <ul>
      <li>CD11c in groups: T-cell-myeloid interactions, Myeloid cells</li>
      <li>CD8a in groups: T-cell-myeloid interactions, T-cells</li>
      <li>CD163 in groups: T-cell-myeloid interactions, Myeloid cells</li>
      <li>FOXP3 in groups: T-cell-myeloid interactions, T-cells</li>
      <li>PD1 in groups: T-cell-myeloid interactions, Functional markers</li>
    </ul>
  </body>
</html>
